- Home
- RMR vs VERV Comparison
RMR vs VERV Comparison
Compare RMR & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- VERV
- Stock Information
- Founded
- RMR 1986
- VERV 2018
- Country
- RMR United States
- VERV United States
- Employees
- RMR N/A
- VERV N/A
- Industry
- RMR Professional Services
- VERV Medicinal Chemicals and Botanical Products
- Sector
- RMR Consumer Discretionary
- VERV Health Care
- Exchange
- RMR Nasdaq
- VERV Nasdaq
- Market Cap
- RMR 425.8M
- VERV 382.5M
- IPO Year
- RMR N/A
- VERV 2021
- Fundamental
- Price
- RMR $25.53
- VERV $5.46
- Analyst Decision
- RMR Buy
- VERV Strong Buy
- Analyst Count
- RMR 2
- VERV 4
- Target Price
- RMR $32.00
- VERV $26.00
- AVG Volume (30 Days)
- RMR 61.5K
- VERV 1.2M
- Earning Date
- RMR 11-12-2024
- VERV 11-05-2024
- Dividend Yield
- RMR 7.08%
- VERV N/A
- EPS Growth
- RMR N/A
- VERV N/A
- EPS
- RMR N/A
- VERV N/A
- Revenue
- RMR $191,259,000.00
- VERV $20,648,000.00
- Revenue This Year
- RMR $287.15
- VERV $57.08
- Revenue Next Year
- RMR N/A
- VERV N/A
- P/E Ratio
- RMR N/A
- VERV N/A
- Revenue Growth
- RMR N/A
- VERV 279.70
- 52 Week Low
- RMR $21.60
- VERV $4.31
- 52 Week High
- RMR $28.82
- VERV $20.12
- Technical
- Relative Strength Index (RSI)
- RMR 55.68
- VERV 57.24
- Support Level
- RMR $25.08
- VERV $4.37
- Resistance Level
- RMR $26.06
- VERV $5.86
- Average True Range (ATR)
- RMR 0.41
- VERV 0.32
- MACD
- RMR 0.02
- VERV 0.12
- Stochastic Oscillator
- RMR 58.59
- VERV 73.40
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.